Treace Medical Concepts Inc
TMCI2.420USD
-0.020-0.82%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
154.17MMarket Cap
LossP/E TTM
More Details of Treace Medical Concepts Inc Company
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Treace Medical Concepts Inc Info
Ticker SymbolTMCI
Company nameTreace Medical Concepts Inc
IPO dateApr 23, 2021
CEOTreace (John T)
Number of employees477
Security typeOrdinary Share
Fiscal year-endApr 23
Address100 Palmetto Park Place
CityPONTE VEDRA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code32081
Phone19043735940
Websitehttps://www.treace.com/
Ticker SymbolTMCI
IPO dateApr 23, 2021
CEOTreace (John T)
Company Executives of Treace Medical Concepts Inc
Name
Name/Position
Position
Shareholding
Change
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.40K
-0.33%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
25.00K
-6.14%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Ms. Elizabeth S. (Betsy) Hanna
Ms. Elizabeth S. (Betsy) Hanna
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.40K
-0.33%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
25.00K
-6.14%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Tue, Nov 25
Updated: Tue, Nov 25
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Treace (John T.)
18.37%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.29%
Other
56.62%
Shareholders
Shareholders
Proportion
Treace (John T.)
18.37%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.29%
Other
56.62%
Shareholder Types
Shareholders
Proportion
Individual Investor
25.43%
Investment Advisor/Hedge Fund
23.25%
Hedge Fund
18.89%
Investment Advisor
16.47%
Research Firm
2.22%
Bank and Trust
0.31%
Pension Fund
0.04%
Family Office
0.03%
Insurance Company
0.03%
Other
13.33%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
338
38.30M
60.11%
-18.99M
2025Q2
369
55.28M
87.88%
-20.58M
2025Q1
378
54.40M
86.48%
-21.10M
2024Q4
366
54.35M
86.91%
-21.27M
2024Q3
360
58.92M
95.05%
-18.98M
2024Q2
346
57.87M
93.51%
-12.18M
2024Q1
319
59.01M
95.72%
-10.84M
2023Q4
318
57.97M
94.48%
-4.76M
2023Q3
299
57.85M
94.48%
-5.12M
2023Q2
290
57.64M
94.33%
-3.44M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Treace (John T.)
11.70M
18.53%
-159.07K
-1.34%
Mar 24, 2025
Armistice Capital LLC
6.26M
9.91%
+49.00K
+0.79%
Jun 30, 2025
William Blair Investment Management, LLC
3.10M
4.91%
+39.28K
+1.28%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.28M
5.2%
-119.04K
-3.50%
Jun 30, 2025
The Vanguard Group, Inc.
2.73M
4.31%
+20.22K
+0.75%
Jun 30, 2025
Gagnon Securities LLC
2.25M
3.56%
-459.82K
-16.97%
Jun 30, 2025
Treace (James T)
1.78M
2.82%
--
--
Mar 24, 2025
Millennium Management LLC
1.52M
2.4%
+1.07M
+241.03%
Jun 30, 2025
CIBC Private Wealth Management
1.69M
2.67%
-606.00K
-26.42%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
908.03K
1.44%
+409.11K
+82.00%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares U.S. Medical Devices ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Fidelity Enhanced Small Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Morningstar Small-Cap ETF
0%
View more
iShares U.S. Medical Devices ETF
Proportion0.04%
Franklin US Small Cap Multifactor Index ETF
Proportion0.04%
iShares Russell 2000 Growth ETF
Proportion0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.01%
Schwab U.S. Small-Cap ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
Fidelity Enhanced Small Cap ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
iShares Morningstar Small-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Treace Medical Concepts Inc?
The top five shareholders of Treace Medical Concepts Inc are:
Treace (John T.) holds 11.70M shares, accounting for 18.53% of the total shares.
Armistice Capital LLC holds 6.26M shares, accounting for 9.91% of the total shares.
William Blair Investment Management, LLC holds 3.10M shares, accounting for 4.91% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 3.28M shares, accounting for 5.20% of the total shares.
The Vanguard Group, Inc. holds 2.73M shares, accounting for 4.31% of the total shares.
Treace (John T.) holds 11.70M shares, accounting for 18.53% of the total shares.
Armistice Capital LLC holds 6.26M shares, accounting for 9.91% of the total shares.
William Blair Investment Management, LLC holds 3.10M shares, accounting for 4.91% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 3.28M shares, accounting for 5.20% of the total shares.
The Vanguard Group, Inc. holds 2.73M shares, accounting for 4.31% of the total shares.
What are the top three shareholder types of Treace Medical Concepts Inc?
The top three shareholder types of Treace Medical Concepts Inc are:
Treace (John T.)
Armistice Capital LLC
William Blair Investment Management, LLC
Treace (John T.)
Armistice Capital LLC
William Blair Investment Management, LLC
How many institutions hold shares of Treace Medical Concepts Inc (TMCI)?
As of 2025Q3, 338 institutions hold shares of Treace Medical Concepts Inc, with a combined market value of approximately 38.30M, accounting for 60.11% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -27.77%.
What is the biggest source of revenue for Treace Medical Concepts Inc?
In --, the -- business generated the highest revenue for Treace Medical Concepts Inc, amounting to -- and accounting for --% of total revenue.
